Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
- Jan 12, 2021 (filed on Jan 14, 2021)Insider Name:Kiani Joe EOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-3,403Price:$280.32
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Reynolds Craig BOwnership Type:Direct OwnershipSecurities:Non-Qualified Stock Option (Right to Buy)Nature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-10,000Price:$23.04
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Reynolds Craig BOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-10,000Price:$279.74
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Reynolds Craig BOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:10,000Price:$23.04
- Jan 11, 2021 (filed on Jan 11, 2021)Insider Name:Kiani Joe EOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-9,034Price:$280.45
- Jan 08, 2021 (filed on Jan 11, 2021)Insider Name:Kiani Joe EOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-52,698Price:$281.93
- Jan 07, 2021 (filed on Jan 11, 2021)Insider Name:Kiani Joe EOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,542Price:$280.05
- Jan 02, 2021 (filed on Jan 06, 2021)Insider Name:Lee YongsamOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-2,000Price:--
- Jan 02, 2021 (filed on Jan 06, 2021)Insider Name:Lee YongsamOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:2,000Price:--
- Jan 02, 2021 (filed on Jan 06, 2021)Insider Name:Coleman JonOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-2,000Price:--
Filings by filing date
- Jan 12, 2021 (filed on Jan 14, 2021)Insider Name:Kiani Joe EOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-3,403Price:$280.32
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Reynolds Craig BOwnership Type:Direct OwnershipSecurities:Non-Qualified Stock Option (Right to Buy)Nature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-10,000Price:$23.04
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Reynolds Craig BOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-10,000Price:$279.74
- Jan 11, 2021 (filed on Jan 13, 2021)Insider Name:Reynolds Craig BOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:10,000Price:$23.04
- Jan 11, 2021 (filed on Jan 11, 2021)Insider Name:Kiani Joe EOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-9,034Price:$280.45
- Jan 08, 2021 (filed on Jan 11, 2021)Insider Name:Kiani Joe EOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-52,698Price:$281.93
- Jan 07, 2021 (filed on Jan 11, 2021)Insider Name:Kiani Joe EOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-1,542Price:$280.05
- Jan 02, 2021 (filed on Jan 06, 2021)Insider Name:Lee YongsamOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-2,000Price:--
- Jan 02, 2021 (filed on Jan 06, 2021)Insider Name:Lee YongsamOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:2,000Price:--
- Jan 02, 2021 (filed on Jan 06, 2021)Insider Name:Coleman JonOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-2,000Price:--
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 52 Discovery IRVINE CA 92618-3105 |
Tel: | 1-949-2977077 |
Website: | https://www.masimo.com |
IR: | See website |
Key People | ||
Joseph E. Kiani Chairman of the Board, Chief Executive Officer | Micah W. Young Chief Financial Officer, Executive Vice President | Jon Coleman President - Worldwide Sales, Professional Services and Medical Affairs |
Bilal Muhsin Chief Operating Officer | Yongsam Lee Executive Vice President, Chief Information Officer | Tom Samuel McClenahan Executive Vice President, General Counsel, Corporate Secretary |
Tao Levy Executive Vice President - Business Development | Anand Sampath Executive Vice President - Operations & Clinical Research | J. Todd Koning Chief Accounting Officer |
Business Overview |
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive monitoring of blood constituents with an optical signature, optical organ oximetry monitoring, electrical, brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. It offers Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be monitored through a personal computer-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones. |
Financial Overview |
For the 39 weeks ended 26 September 2020, MasimoCorporation revenues increased 23% to $848.7M. Net incomeincreased 18% to $169.6M. Revenues reflect United Statessegment increase of 22% to $571.2M, Europe, Middle East andAfrica segment increase of 30% to $176.8M. Net income waspartially offset by Selling, general and administrativeincrease of 20% to $278.7M (expense), Research anddevelopment increase of 24% to $87M (expense). |
Employees: | 1,600 as of Dec 28, 2019 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $13,692M as of Sep 26, 2020 |
Annual revenue (TTM): | $1,096M as of Sep 26, 2020 |
EBITDA (TTM): | $279.11M as of Sep 26, 2020 |
Net annual income (TTM): | $222.55M as of Sep 26, 2020 |
Free cash flow (TTM): | $137.53M as of Sep 26, 2020 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 55,055,000 as of Sep 26, 2020 |
Index Membership: | S&P 400 Mid Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |